OSUR Orasure Technologies (OSUR) Insider Trading, Ownership & Congress Trades
Medical Devices · Surgical & medical instruments & apparatus · CIK 0001116463
Activist 13D
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
65
13F, latest reported quarter
What the filings say about OSUR
Insiders, 180 days
+$224.8K net bought
1 buyer
Activist stakes (13D), 180 days
1 filing
Largest: 5.7% of the class
Orasure Technologies insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, ORASURE TECHNOLOGIES INC insiders bought a net $224.8K of stock across 21 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on May 13, 2026.
- +31.2% median (+31.2% mean) 90-day return after 2 previous buys.
- The trade is 22.0% of the 113,462 shares held after it.
- No other insider bought within 30 days.
- 65 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Boyd Steven Kyle bought about $74.8K of OSUR on May 14, 2026; 65 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 12, 2026.
- The trade is 28.3% of the 88,462 shares held after it.
- No other insider bought within 30 days.
- 65 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Boyd Steven Kyle bought about $75.5K of OSUR on May 13, 2026; 65 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 39.4% of the 63,462 shares held after it.
- No other insider bought within 30 days.
- 65 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Boyd Steven Kyle bought about $74.5K of OSUR on May 12, 2026; 65 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Mar 13, 2026.
- +35.4% median (+21.7% mean) 90-day return after 3 previous buys.
- The trade is 5.5% of the 589,562 shares held after it.
- 1 other insider bought within 30 days.
- 65 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer McGrath Kenneth J bought about $94.6K of OSUR on Mar 20, 2026, the largest insider purchase at the company since 2025; 1 other insider bought within 30 days and 65 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Mar 13, 2026.
- -11.5% median (+3.7% mean) 90-day return after 3 previous buys.
- The trade is 1.5% of the 2,190,874 shares held after it.
- 1 other insider bought within 30 days.
- 65 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO EGLINTON MANNER CARRIE bought about $94.6K of OSUR on Mar 20, 2026, the largest insider purchase at the company since 2025; 1 other insider bought within 30 days and 65 funds added in the latest 13F quarter.21 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$224.8K over 180 days
more than 79% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
65 funds bought in last quarter
more than 51% of Medical Devices
Revenue
-38.1% year over year
below 94% of Medical Devices
Margin
-59.8% net margin
below 70% of Medical Devices
Buybacks
$7.0M repurchased, FY to 2026-06-30
below 69% of Medical Devices
Short interest
5.2% of the float short (float per yahoo 2026-10-26) · 4.5 days to cover · settled 2026-09-30
more than 59% of Medical Devices
The situation: each line is one rule over one dataset
Islet Management, LP disclosed a 5%+ stake (0.7%) in the last six months.
What changed in the last 30 days
Oct 27Insider buying stopped: no purchases in 90 days after 3 in the prior 90
Why it matters
The absence is the signal: 3 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.
Watch OSUR
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+43.9%12M
Insider buy13D/G stake
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns OSUR: institutional holders (13F)
13F holdings, latest reported quarter
6,256,762 sh
$27.9M
4,685,432 sh
$20.9M
3,797,682 sh
$16.9M
3,018,907 sh
$13.5M
2,857,974 sh
$12.7M
Congress trades in OSUR
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
13D: intends to influence · 13G: passive
Islet Management, LP
Activist 13D · 2026-09-17
0.7%
Samuels, Joseph Aron
Activist 13D · 2026-09-17
0.7%
YA II PN, Ltd.
Activist 13D · 2026-09-17
5.7%
YA Global Investments II (U.S.), LP
Activist 13D · 2026-09-17
5.7%
Yorkville Advisors Global, LP
Activist 13D · 2026-09-17
5.7%
OSUR planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
OSUR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
FULLERTHALER BEHAVIORAL MICRO-CAP EQUITY FUND
$319.1K position · as of 2026-06-30
1.1%
Invesco NASDAQ Future Gen 200 ETF
$104.9K position · as of 2026-05-31
0.6%
Ultra-Small Company Market Fund
$468.3K position · as of 2026-06-30
0.3%
Neuberger Intrinsic Value Fund
$4.7M position · as of 2026-05-31
0.3%
NVIT Small Cap Value Fund
$464.9K position · as of 2026-06-30
0.2%
First Eagle Small Cap Opportunity Fund
$4.7M position · as of 2026-07-31
0.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows a net $224.8K bought by insiders over 180 days, 65 funds added last quarter. Each figure is a federal filing, dated the day it went public.
OSUR financials
Revenue growth
-38.1%
XBRL, annual
Net margin
-59.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$112.4M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM OSUR
| FY Dec 2025 | $115.0M |
| FY Dec 2024 | $185.8M |
| FY Dec 2023 | $405.5M |
| FY Dec 2022 | $387.5M |
| FY Dec 2021 | $233.7M |
| Jun 2026 | $30.6M |
| Mar 2026 | $27.9M |
| Dec 2025 | $26.8M |
| Sep 2025 | $27.1M |
| Jun 2025 | $31.2M |
| Mar 2025 | $29.9M |
| Dec 2024 | $37.4M |
| Sep 2024 | $39.9M |
At each fiscal year end
Single quarter
Net margin, TTM
-43.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM OSUR
| FY Dec 2025 | -59.8% |
| FY Dec 2024 | -10.5% |
| FY Dec 2023 | +13.2% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | -9.8% |
| Jun 2026 | +20.4% |
| Mar 2026 | -80.1% |
| Dec 2025 | -72.1% |
| Sep 2025 | -50.6% |
| Jun 2025 | -63.0% |
| Mar 2025 | -53.6% |
| Dec 2024 | -28.8% |
| Sep 2024 | -11.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$48.1M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM OSUR
| FY Dec 2025 | -$53.2M |
| FY Dec 2024 | $23.6M |
| FY Dec 2023 | $135.8M |
| FY Dec 2022 | -$54.0M |
| FY Dec 2021 | -$57.3M |
| Jun 2026 | -$12.3M |
| Mar 2026 | -$14.8M |
| Dec 2025 | -$9.9M |
| Sep 2025 | -$11.0M |
| Jun 2025 | -$12.2M |
| Mar 2025 | -$20.2M |
| Dec 2024 | -$347.0K |
| Sep 2024 | $12.5M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity OSUR
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt OSUR
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-14.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity OSUR
| FY Dec 2025 | -18.3% |
| FY Dec 2024 | -4.6% |
| FY Dec 2023 | +13.5% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | -5.9% |
| Jun 2026 | -14.1% |
| Mar 2026 | -21.2% |
| Dec 2025 | -18.3% |
| Sep 2025 | -15.3% |
| Jun 2025 | -12.7% |
| Mar 2025 | -7.8% |
| Dec 2024 | -4.6% |
| Sep 2024 | +2.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-12.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets OSUR
| FY Dec 2025 | -15.6% |
| FY Dec 2024 | -4.1% |
| FY Dec 2023 | +11.6% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | -5.0% |
| Jun 2026 | -12.2% |
| Mar 2026 | -17.9% |
| Dec 2025 | -15.6% |
| Sep 2025 | -13.6% |
| Jun 2025 | -11.2% |
| Mar 2025 | -6.9% |
| Dec 2024 | -4.1% |
| Sep 2024 | +2.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital OSUR
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-14.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed OSUR
| FY Dec 2025 | -17.8% |
| FY Dec 2024 | -6.4% |
| FY Dec 2023 | +8.0% |
| FY Dec 2022 | -5.8% |
| FY Dec 2021 | -2.5% |
| Jun 2026 | -14.6% |
| Mar 2026 | -20.2% |
| Dec 2025 | -17.8% |
| Sep 2025 | -15.7% |
| Jun 2025 | -12.9% |
| Mar 2025 | -8.9% |
| Dec 2024 | -6.4% |
| Sep 2024 | -2.8% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing OSUR
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 11.39x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | 28.47x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value OSUR
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-16.9%
TTM free cash flow over market value at close 2026-10-23
FCF yield OSUR
| FY Dec 2025 | -30.7% |
| FY Dec 2024 | +8.8% |
| FY Dec 2023 | +22.5% |
| FY Dec 2022 | -15.4% |
| FY Dec 2021 | -9.1% |
| Jun 2026 | -15.7% |
| Mar 2026 | -23.1% |
| Dec 2025 | -30.7% |
| Sep 2025 | -18.6% |
| Jun 2025 | -9.0% |
| Mar 2025 | -0.7% |
| Dec 2024 | +8.8% |
| Sep 2024 | +20.1% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing OSUR
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $115.0M | $185.8M | $405.5M | $387.5M |
| Gross profit | $48.2M | $79.4M | $171.7M | $148.4M |
| Operating income | -$72.0M | -$28.2M | $32.7M | -$22.2M |
| Net income | -$68.7M | -$19.5M | $53.7M | -$17.1M |
| EPS (diluted) | -0.94 | -0.26 | 0.72 | -0.24 |
| Operating cash flow | -$49.0M | $27.4M | $141.6M | -$47.2M |
| Cash | $199.3M | $267.8M | $290.4M | $84.0M |
| Buybacks | $15.0M | $0 | $0 | $2.3M |
SEC XBRL, fiscal years, as known on 2026-10-27
OSUR Stock Sonar score 5/7 axes
Find similar shapesCompareOSUR ranks highest on insider conviction (65th percentile) and risk and compliance (63rd), and lowest on growth (6th), among Medical Devices peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
OSUR filings, in plain words
Are Orasure Technologies insiders buying or selling OSUR?
In the 180 days to 2026-10-27, Orasure Technologies insiders were net buyers, a net $224.8K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-27, Orasure Technologies insiders were net buyers of OSUR, a net $224.8K across purchases and sales reported on Form 4 by 1 buyer. 1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 5.7% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
